Experimental cell injection aims to heal damaged kidneys
NCT ID NCT07275788
Summary
This early-stage study is testing the safety of an experimental treatment called REGEND003, which contains human kidney repair cells. Researchers want to see if injecting these cells directly into the kidneys is safe and tolerable for people with type 2 diabetes and chronic kidney disease. The study will enroll 15 participants to monitor for side effects and gather initial information on kidney function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) AND CHRONIC KIDNEY DISEASE (CKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Tongji Hospital
RECRUITINGShanghai, 200000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.